title: β-globin gene transfer to human bone marrow for sickle cell disease.
abstract: Autologous hematopoietic stem cell gene therapy is an approach to treating sickle cell disease (SCD) patients that may result in lower morbidity than allogeneic transplantation. We examined the potential of a lentiviral vector (LV) (CCL-βAS3-FB) encoding a human hemoglobin (HBB) gene engineered to impede sickle hemoglobin polymerization (HBBAS3) to transduce human BM CD34+ cells from SCD donors and prevent sickling of red blood cells produced by in vitro differentiation. The CCL-βAS3-FB LV transduced BM CD34+ cells from either healthy or SCD donors at similar levels, based on quantitative PCR and colony-forming unit progenitor analysis. Consistent expression of HBBAS3 mRNA and HbAS3 protein compromised a fourth of the total β-globin-like transcripts and hemoglobin (Hb) tetramers. Upon deoxygenation, a lower percentage of HBBAS3-transduced red blood cells exhibited sickling compared with mock-transduced cells from sickle donors. Transduced BM CD34+ cells were transplanted into immunodeficient mice, and the human cells recovered after 2-3 months were cultured for erythroid differentiation, which showed levels of HBBAS3 mRNA similar to those seen in the CD34+ cells that were directly differentiated in vitro. These results demonstrate that the CCL-βAS3-FB LV is capable of efficient transfer and consistent expression of an effective anti-sickling β-globin gene in human SCD BM CD34+ progenitor cells, improving physiologic parameters of the resulting red blood cells.
authors.forename: Zulema
authors.initials: Z
authors.lastname: Romero
authors.forename: Fabrizia
authors.initials: F
authors.lastname: Urbinati
authors.forename: Sabine
authors.initials: S
authors.lastname: Geiger
authors.forename: Aaron R
authors.initials: AR
authors.lastname: Cooper
authors.forename: Jennifer
authors.initials: J
authors.lastname: Wherley
authors.forename: Michael L
authors.initials: ML
authors.lastname: Kaufman
authors.forename: Roger P
authors.initials: RP
authors.lastname: Hollis
authors.forename: Rafael Ruiz
authors.initials: RR
authors.lastname: de Assin
authors.forename: Shantha
authors.initials: S
authors.lastname: Senadheera
authors.forename: Arineh
authors.initials: A
authors.lastname: Sahagian
authors.forename: Xiangyang
authors.initials: X
authors.lastname: Jin
authors.forename: Alyse
authors.initials: A
authors.lastname: Gellis
authors.forename: Xiaoyan
authors.initials: X
authors.lastname: Wang
authors.forename: David
authors.initials: D
authors.lastname: Gjertson
authors.forename: Satiro
authors.initials: S
authors.lastname: Deoliveira
authors.forename: Pamela
authors.initials: P
authors.lastname: Kempert
authors.forename: Sally
authors.initials: S
authors.lastname: Shupien
authors.forename: Hisham
authors.initials: H
authors.lastname: Abdel-Azim
authors.forename: Mark C
authors.initials: MC
authors.lastname: Walters
authors.forename: Herbert J
authors.initials: HJ
authors.lastname: Meiselman
authors.forename: Rosalinda B
authors.initials: RB
authors.lastname: Wenby
authors.forename: Theresa
authors.initials: T
authors.lastname: Gruber
authors.forename: Victor
authors.initials: V
authors.lastname: Marder
authors.forename: Thomas D
authors.initials: TD
authors.lastname: Coates
authors.forename: Donald B
authors.initials: DB
authors.lastname: Kohn